A phase I clinical trial of a combination of mitoxantrone, 5- fluorouracil, and high-dose leucovorin given on a day 1 and day 8 schedule to patients with metastatic breast cancer

C. L. Vogel, E. G. Gomez

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'A phase I clinical trial of a combination of mitoxantrone, 5- fluorouracil, and high-dose leucovorin given on a day 1 and day 8 schedule to patients with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences